Professor Desmond Yip
Content navigation
About
Professor Desmond Yip is the Clinical Director of Medical Oncology at The Canberra Hospital, Professor at the ANU Medical School and Adjunct Professor at the University of Canberra. He is a full time practicing medical oncologist. His main clinical and research interests are in the area of gastrointestinal oncology and developmental therapeutics of cancer drugs. He also has subspecialty interests in renal cell carcinoma and gastrointestinal stromal tumours. He is presently a member of the Cancer Institute NSW eviQ Medical Oncology Reference Committee, Executive Member of the Medical Oncology Group of Australia, Treasurer of the Private Cancer Physicians of Australia and former Chair of the Clinical Oncology Group of Australia Gastrointestinal Group. He is a member of the Australian Government Professional Services Review Panel. He an active member of the Australasian Gastrointestinal Trials Group serving as current Chair of the Grants Committee, member of study management committees and Study Chair of an international multicentre randomised collaborative trial in gastrointestinal stromal tumours. He has been involved in the publication of over 140 journal articles and invited book chapters. He has been involved with two iterations of a Cochrane Collaboration Systematic Review in pancreatic cancer and also on the working party to update the Cancer Council Australia Clinical Guidelines on colorectal cancer. Professor Yip has worked in collaboration with the John James Foundation, Australian Government Department of Foreign Affairs and Trade (DFAT)/ Royal Australasian College of Physicians (RACP) Pacific Islands Program and Doctors Assisting in South-Pacific Islands (DAISI) to help develop cancer services in the Solomon Islands through in-country multidisciplinary missions, mentoring, supply of equipment and facilitating staff training visits to Canberra. He is present Chair of the Clinical Oncology Society of Australia Global Oncology Group.
Affiliations
Research interests
- Gastrointestinal cancers
- Gastrointestinal stromal tumours
- Targeted therapies
- Global oncology
Areas of Expertise
- Oncology And Carcinogenesis
Projects and Grants
AUTO-CHECK study: Molecular determinants of autoimmunity and immune related adverse events in advanced cancer patients treated with immune checkpoint inhibitors (Secondary Investigator)
Related Websites
Teaching information
Oncology
Location
Department of Medical Oncology, Canberra Hospital, Yamba Drive, Garran ACT 2605